0001209191-20-024511.txt : 20200415
0001209191-20-024511.hdr.sgml : 20200415
20200415173058
ACCESSION NUMBER: 0001209191-20-024511
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200415
FILED AS OF DATE: 20200415
DATE AS OF CHANGE: 20200415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patterson Joshua F.
CENTRAL INDEX KEY: 0001805702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 20794528
MAIL ADDRESS:
STREET 1: C/O AKCEA THERAPEUTICS, INC.
STREET 2: 22 BOSTON WHARF ROAD, 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-207-0202
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-15
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001805702
Patterson Joshua F.
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR
BOSTON
MA
02210
0
1
0
0
General Counsel
Common Stock
2020-04-15
4
A
0
12500
0.00
A
27114
D
Represents restricted stock unit award granted under the Issuer's 2015 Equity Incentive Plan.
/s/ Joshua F. Patterson
2020-04-15